Hemostatic Evaluation With Viscoelastic Coagulation Monitor: A Nicu Experience.
VCM
hemorrhage
hemostasis
newborn
thromboelastography
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2022
2022
Historique:
received:
01
04
2022
accepted:
25
04
2022
entrez:
27
5
2022
pubmed:
28
5
2022
medline:
28
5
2022
Statut:
epublish
Résumé
Viscoelastic coagulation tests provide valuable information in neonatal intensive care units (NICUs), but the lack of reference intervals still limits their decision-making power according to gestational age. The aim of the present study is to evaluate the hemostasis of a cohort of full-term (FT) and late-preterm (LP) infants using the viscoelastic coagulation monitor (VCM®) system, a new portable device that uses untreated whole blood. An observational study was performed to identify non-coagulopathic FT and LP infants admitted to III° level NICU (January 2020 to December 2021) with a VCM test in the first 72 h of life. Forty-five patients were enrolled, 26 FT and 19 LP. No statistical differences in hemostatic parameters were observed between FT and LP nor between stable and unstable neonates. Clotting time (CT) was positive correlated with PT ( The viscoelastic profile of FT and LP infants assessed with VCM showed a hemostatic competence characterized by accelerated coagulation and clot formation time, in line with other viscoelastic techniques. VCM system provides promising applications in the NICU setting.
Sections du résumé
Background
UNASSIGNED
Viscoelastic coagulation tests provide valuable information in neonatal intensive care units (NICUs), but the lack of reference intervals still limits their decision-making power according to gestational age. The aim of the present study is to evaluate the hemostasis of a cohort of full-term (FT) and late-preterm (LP) infants using the viscoelastic coagulation monitor (VCM®) system, a new portable device that uses untreated whole blood.
Methods
UNASSIGNED
An observational study was performed to identify non-coagulopathic FT and LP infants admitted to III° level NICU (January 2020 to December 2021) with a VCM test in the first 72 h of life.
Results
UNASSIGNED
Forty-five patients were enrolled, 26 FT and 19 LP. No statistical differences in hemostatic parameters were observed between FT and LP nor between stable and unstable neonates. Clotting time (CT) was positive correlated with PT (
Conclusions
UNASSIGNED
The viscoelastic profile of FT and LP infants assessed with VCM showed a hemostatic competence characterized by accelerated coagulation and clot formation time, in line with other viscoelastic techniques. VCM system provides promising applications in the NICU setting.
Identifiants
pubmed: 35620150
doi: 10.3389/fped.2022.910646
pmc: PMC9127261
doi:
Types de publication
Journal Article
Langues
eng
Pagination
910646Informations de copyright
Copyright © 2022 Amelio, Raffaeli, Amodeo, Gulden, Cortesi, Manzoni, Pesenti, Ghirardello, Mosca and Cavallaro.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Semin Thromb Hemost. 2021 Oct;47(7):875-884
pubmed: 34130345
Br J Anaesth. 2010 Dec;105(6):827-35
pubmed: 20884636
Thromb Haemost. 2010 Feb;103(2):344-50
pubmed: 20076842
Eur J Pediatr. 2021 Dec;180(12):3455-3470
pubmed: 34131816
Haematologica. 2008 Aug;93(8):1256-9
pubmed: 18403390
Front Pediatr. 2021 Mar 02;9:627715
pubmed: 33738269
Arch Dis Child Fetal Neonatal Ed. 2017 Jan;102(1):F79-F84
pubmed: 27178714
Br J Anaesth. 2012 Jan;108(1):36-41
pubmed: 22086509
Am J Hematol. 2014 Feb;89(2):228-32
pubmed: 24123050
Am J Clin Pathol. 2008 Jul;130(1):99-102
pubmed: 18550478
Diagnostics (Basel). 2021 Oct 27;11(11):
pubmed: 34829342
Transfusion. 2014 Mar;54(3):627-32:quiz 626
pubmed: 23834237
J Pediatr Hematol Oncol. 2008 Mar;30(3):210-3
pubmed: 18376283
Blood. 1988 Nov;72(5):1651-7
pubmed: 3179444
Thromb Haemost. 2021 Feb;121(2):131-139
pubmed: 32838471
Eur J Haematol. 2021 Feb;106(2):175-183
pubmed: 33053216
J Matern Fetal Neonatal Med. 2018 Oct;31(19):2599-2604
pubmed: 28662614
Br J Haematol. 2009 Oct;147(1):77-82
pubmed: 19659548
Br J Haematol. 2005 Nov;131(4):417-30
pubmed: 16281932
Platelets. 2022 Jan 2;33(1):14-22
pubmed: 34392772
J Matern Fetal Neonatal Med. 2015;28(15):1779-83
pubmed: 25245227
Diagnostics (Basel). 2021 Oct 21;11(11):
pubmed: 34829302
Blood. 1987 Jul;70(1):165-72
pubmed: 3593964
ASAIO J. 2021 Mar 1;67(3):254-262
pubmed: 33627598
Blood Rev. 2010 Mar;24(2):63-8
pubmed: 20074839
J Matern Fetal Neonatal Med. 2021 Jul 25;:1-7
pubmed: 34304670
Arch Dis Child Fetal Neonatal Ed. 2020 Jul;105(4):412-418
pubmed: 31704736
Pediatr Clin North Am. 2013 Dec;60(6):1407-17
pubmed: 24237979